Bio-Synergy targets India sales with DNA testing kit launch
In short
Bio-Synergy and Kynora Life Sciences launched DNA and epigenetics testing kits in India. The kits are priced between ₹25,000 and ₹85,000, and the company is targeting £3-5 million in India sales.
This matters because the products are aimed at personalised wellness in a new market. The report does not say how many kits will be sold or when the sales target may be reached.
What the reporting says
Bio-Synergy, a UK health science firm, partnered with Kynora Life Sciences to launch DNA and epigenetics testing kits in India, with prices reportedly between ₹25,000 and ₹85,000. The reporting says the products target personalised wellness and that Bio-Synergy is aiming for £3-5 million in India sales. It does not state launch timing, unit volumes, or whether the target has been achieved.
Why it matters
Bio-Synergy partnered with Kynora Life Sciences to launch DNA and epigenetics testing kits in India, with reported prices of ₹25,000 to ₹85,000 and a sales goal of £3-5 million in India. The story links the launch to personalised wellness demand, but it does not state launch dates, expected volumes, or regulatory clearances. The commercial outcome is unknown.